DNA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

DNAGinkgo Bioworks Holdings, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

DNAGinkgo Bioworks Holdings, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

DNAGinkgo Bioworks Holdings, Inc.

11.25· pre 11.60

Mkt cap$754.9MRevenue$20MQ2 FY26Revenue$150MFY25

AMGNAmgen Inc

466.31· pre 465.85

Pre-marketSep 2 '83

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

Pre-marketSep 2 '83

DNAGinkgo Bioworks Holdings, Inc.

AMGNAmgen Inc

11.25pre 11.60

Price

466.31pre 465.85

$754.9M

Mkt cap

$251.9B

Q2 FY26$20M

Revenue

$10.1BQ2 FY26

FY25$150M

Revenue

$36.8BFY25

DNA11.25vsAMGN466.31Pre-marketSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DNA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DNA 6

TWSTTwistsupplier

—Google Cloudunlistedsupplier

—Virica Biotechunlistedsupplier

—BiomEditunlistedcustomer

2 more · DNA chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

DNA, solidAMGN, dashed